TREX1 and Aicardi-Goutieres syndrome: For instance, inhibitors targeting cGAS significantly downregulated IFN expression in TREX1-/- PMBCs in AGS model mice, showing excellent potential for drug development in the treatment of autoimmune diseases caused by DNA accumulation such as AGS and SLE.